ArticlePloS one2026
Multi-phantom SAR-assessed ultra-compact dual-band millimeter-wave (mmWave) antenna optimised for 5G smartphones.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper presents an ultra-compact millimetre-wave antenna designed to support 28 GHz and 38 GHz 5G smartphone applications. To ensure safe and reliable integration, a comprehensive specific absorption rate (SAR) evaluation was carried out using three anatomically realistic head phantoms: a full-head, a skeletal skull, and an isolated brain model. The fabricated prototype demonstrated robust dual-band performance with close agreement between simulated and measured results. Importantly, SAR levels remained well below international safety limits, confirming both compliance and user safety. These results highlight the antenna's strong potential for enabling next-generation high-data-rate communications in compact mobile devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.